Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2018-06-12
- Employees
- -
- Market Cap
- -
- Website
- http://yirui-pharma.com
Topical YR001 Ointment in Adult with Mild to Moderate Atopic Dermatitis
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2025-03-25
- Target Recruit Count
- 36
- Registration Number
- NCT06309355
- Locations
- 🇺🇸
Encore Medical Research -Boynton Beach, Boynton Beach, Florida, United States
🇺🇸Encore Medical Research-Hollywood, Hollywood, Florida, United States
🇺🇸Encore Medical Research-Weston, Weston, Florida, United States
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
Phase 1
Completed
- Conditions
- PsoriasisAtopic Dermatitis
- Interventions
- Drug: YR001 Dose A on low body surface areaDrug: YR001 Dose B on middle body surface areaDrug: YR001 Dose A on high body surface areaDrug: YR001 Dose B on low body surface areaDrug: YR001 Dose B on high body surface areaDrug: Placebo on low body surface areaDrug: Placebo on high body surface areaDrug: YR001 Dose A on high body surface area twice dailyDrug: Placebo on high body surface area twice dailyDrug: YR001 Dose A on middle body surface areaDrug: YR001 Dose B on high body surface area twice dailyDrug: Placebo on middle body surface area
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-01-24
- Target Recruit Count
- 54
- Registration Number
- NCT05718921
- Locations
- 🇺🇸
California Dermatology & Clinical Research Institute, Encinitas, California, United States
© Copyright 2025. All Rights Reserved by MedPath